Jiangsu Hengrui Medicine Co., Ltd. (600276.SS)
CNY 48.7
(0.0%)
CNY 48.7
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 75.17 Million CNY | -23.96% |
| 2022 | 98.86 Million CNY | -34.78% |
| 2021 | 151.58 Million CNY | 0.0% |
| 2020 | - CNY | 0.0% |
| 2019 | - CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| 2015 | - CNY | -100.0% |
| 2014 | 10 Million CNY | 0.0% |
| 2013 | 10 Million CNY | 0.0% |
| 2012 | 10 Million CNY | 0.0% |
| 2011 | 10 Million CNY | -50.0% |
| 2010 | 20 Million CNY | 100.0% |
| 2009 | 10 Million CNY | 0.0% |
| 2008 | - CNY | 0.0% |
| 2007 | - CNY | -100.0% |
| 2006 | 48 Million CNY | 0.0% |
| 2005 | 48 Million CNY | 140.0% |
| 2004 | 20 Million CNY | -82.46% |
| 2003 | 114 Million CNY | 27.37% |
| 2002 | 89.5 Million CNY | -25.42% |
| 2001 | 120 Million CNY | -0.66% |
| 2000 | 120.8 Million CNY | 193.35% |
| 1999 | 41.18 Million CNY | -14.71% |
| 1998 | 48.28 Million CNY | 291.25% |
| 1997 | 12.34 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 78.39 Million CNY | 0.0% |
| 2024 Q2 | 58.27 Million CNY | 0.0% |
| 2024 Q3 | - CNY | 100.0% |
| 2023 Q4 | 75.17 Million CNY | 1.89% |
| 2023 Q1 | 83.91 Million CNY | -15.12% |
| 2023 Q2 | 76.87 Million CNY | -8.39% |
| 2023 FY | 75.17 Million CNY | -23.96% |
| 2023 Q3 | 73.78 Million CNY | -4.03% |
| 2022 Q1 | 143.74 Million CNY | -5.17% |
| 2022 Q3 | 147.27 Million CNY | 11.85% |
| 2022 FY | 98.86 Million CNY | -34.78% |
| 2022 Q4 | 98.86 Million CNY | -32.87% |
| 2022 Q2 | 131.67 Million CNY | -8.4% |
| 2021 Q3 | 49.97 Million CNY | -3.52% |
| 2021 Q4 | 151.58 Million CNY | 203.36% |
| 2021 Q1 | 47.17 Million CNY | 0.0% |
| 2021 FY | 151.58 Million CNY | 0.0% |
| 2021 Q2 | 51.79 Million CNY | 9.79% |
| 2020 Q2 | - CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 Q3 | - CNY | 0.0% |
| 2020 Q4 | - CNY | 0.0% |
| 2020 FY | - CNY | 0.0% |
| 2019 Q3 | - CNY | 0.0% |
| 2019 Q2 | - CNY | 0.0% |
| 2019 FY | - CNY | 0.0% |
| 2019 Q1 | - CNY | -100.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 Q2 | - CNY | 0.0% |
| 2018 Q3 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2018 Q4 | 0.60 CNY | 0.0% |
| 2017 Q1 | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2017 Q3 | - CNY | 0.0% |
| 2017 Q2 | - CNY | 0.0% |
| 2016 Q2 | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| 2016 Q3 | - CNY | 0.0% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 Q4 | - CNY | 0.0% |
| 2015 FY | - CNY | -100.0% |
| 2015 Q4 | - CNY | -100.0% |
| 2015 Q1 | 10 Million CNY | 0.0% |
| 2015 Q2 | 10 Million CNY | 0.0% |
| 2015 Q3 | 10 Million CNY | 0.0% |
| 2014 Q1 | 10 Million CNY | 0.0% |
| 2014 Q3 | 10 Million CNY | 0.0% |
| 2014 Q2 | 10 Million CNY | 0.0% |
| 2014 Q4 | 10 Million CNY | 0.0% |
| 2014 FY | 10 Million CNY | 0.0% |
| 2013 Q1 | 10 Million CNY | 0.0% |
| 2013 Q2 | 10 Million CNY | 0.0% |
| 2013 Q3 | 10 Million CNY | 0.0% |
| 2013 Q4 | 10 Million CNY | 0.0% |
| 2013 FY | 10 Million CNY | 0.0% |
| 2012 Q2 | 10 Million CNY | 0.0% |
| 2012 Q1 | 10 Million CNY | 0.0% |
| 2012 Q4 | 10 Million CNY | 0.0% |
| 2012 FY | 10 Million CNY | 0.0% |
| 2012 Q3 | 10 Million CNY | 0.0% |
| 2011 FY | 10 Million CNY | -50.0% |
| 2011 Q4 | 10 Million CNY | -50.07% |
| 2011 Q3 | 20.03 Million CNY | 0.0% |
| 2011 Q2 | 20.03 Million CNY | 0.15% |
| 2011 Q1 | 20 Million CNY | 0.0% |
| 2010 Q2 | 10 Million CNY | 0.0% |
| 2010 Q4 | 20 Million CNY | 99.5% |
| 2010 FY | 20 Million CNY | 100.0% |
| 2010 Q3 | 10.02 Million CNY | 0.25% |
| 2010 Q1 | 10 Million CNY | 0.0% |
| 2009 FY | 10 Million CNY | 0.0% |
| 2009 Q3 | - CNY | 0.0% |
| 2009 Q1 | - CNY | 0.0% |
| 2009 Q2 | - CNY | 0.0% |
| 2009 Q4 | 10 Million CNY | 0.0% |
| 2008 Q3 | - CNY | 0.0% |
| 2008 FY | - CNY | 0.0% |
| 2008 Q1 | - CNY | 0.0% |
| 2008 Q2 | - CNY | 0.0% |
| 2008 Q4 | - CNY | 0.0% |
| 2007 Q4 | - CNY | 0.0% |
| 2007 Q3 | - CNY | 0.0% |
| 2007 Q2 | - CNY | -100.0% |
| 2007 Q1 | 48 Million CNY | 0.0% |
| 2007 FY | - CNY | -100.0% |
| 2006 Q1 | 48 Million CNY | 0.0% |
| 2006 Q2 | 48 Million CNY | 0.0% |
| 2006 Q3 | 48 Million CNY | 0.0% |
| 2006 FY | 48 Million CNY | 0.0% |
| 2006 Q4 | 48 Million CNY | 0.0% |
| 2005 Q1 | 13 Million CNY | -35.0% |
| 2005 FY | 48 Million CNY | 140.0% |
| 2005 Q2 | 9 Million CNY | -30.77% |
| 2005 Q3 | 48 Million CNY | 433.33% |
| 2005 Q4 | 48 Million CNY | 0.0% |
| 2004 Q1 | 106 Million CNY | -7.02% |
| 2004 Q3 | 49 Million CNY | -47.87% |
| 2004 Q4 | 20 Million CNY | -59.18% |
| 2004 Q2 | 94 Million CNY | -11.32% |
| 2004 FY | 20 Million CNY | -82.46% |
| 2003 Q4 | 114 Million CNY | -11.28% |
| 2003 Q1 | 122.5 Million CNY | 36.87% |
| 2003 Q3 | 128.5 Million CNY | 8.44% |
| 2003 Q2 | 118.5 Million CNY | -3.27% |
| 2003 FY | 114 Million CNY | 27.37% |
| 2002 Q2 | 120 Million CNY | 5.08% |
| 2002 Q1 | 114.2 Million CNY | -4.83% |
| 2002 FY | 89.5 Million CNY | -25.42% |
| 2002 Q4 | 89.5 Million CNY | -15.49% |
| 2002 Q3 | 105.9 Million CNY | -11.75% |
| 2001 FY | 120 Million CNY | -0.66% |
| 2001 Q2 | 110 Million CNY | 0.0% |
| 2001 Q4 | 120 Million CNY | 0.0% |
| 2000 Q4 | 120.8 Million CNY | 0.0% |
| 2000 FY | 120.8 Million CNY | 193.35% |
| 1999 FY | 41.18 Million CNY | -14.71% |
| 1998 FY | 48.28 Million CNY | 291.25% |
| 1997 FY | 12.34 Million CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 35.44 Million CNY | -112.11% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 305.75 Million CNY | 75.413% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 170.1 Million CNY | 55.805% |
| Aurora Optoelectronics Co.,Ltd. | 13.33 Million CNY | -463.796% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 7.23 Million CNY | -939.559% |
| NanJing Pharmaceutical Company Limited | 2.11 Billion CNY | 96.45% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 39.11 Million CNY | -92.213% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | - CNY | -Infinity% |